{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:34:50Z","timestamp":1765233290451,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.amjms.2022.01.023","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T03:46:34Z","timestamp":1646711194000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma"],"prefix":"10.1016","volume":"365","author":[{"given":"Woon Hean","family":"Chong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biplab K.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Beegle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjms.2022.01.023_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1183\/09031936.00060107","article-title":"Occult connective tissue diseases mimicking idiopathic interstitial pneumonias","volume":"31","author":"Tzelepis","year":"2008","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.amjms.2022.01.023_bib0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/jcm6050051","article-title":"Role of autoantibodies in the diagnosis of connective-tissue disease ILD (CTD-ILD) and interstitial pneumonia with autoimmune features (IPAF)","volume":"6","author":"Jee","year":"2017","journal-title":"JCM"},{"issue":"2","key":"10.1016\/j.amjms.2022.01.023_bib0003","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.mayocp.2018.09.002","article-title":"Interstitial lung disease and other pulmonary manifestations in connective tissue diseases","volume":"94","author":"Mira-Avendano","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.amjms.2022.01.023_bib0004","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000196457","article-title":"Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia?","volume":"62","author":"Homma","year":"1995","journal-title":"Respiration"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.023_bib0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00296-009-0878-7","article-title":"The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications","volume":"29","author":"Toya","year":"2009","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.amjms.2022.01.023_bib0006","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1378\/chest.130.4.976","article-title":"Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease","volume":"130","author":"Fischer","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.amjms.2022.01.023_bib0007","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G","article-title":"Systemic sclerosis sine scleroderma: Demographic, clinical, and serologic features and survival in forty-eight patients","volume":"43","author":"Poormoghim","year":"2000","journal-title":"Arthritis Rheumatism"},{"issue":"5","key":"10.1016\/j.amjms.2022.01.023_bib0008","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0002-9343(89)80608-4","article-title":"Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis","volume":"87","author":"Lomeo","year":"1989","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.023_bib0009","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","article-title":"The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement","volume":"47","author":"Hunzelmann","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.amjms.2022.01.023_bib0010","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3899\/jrheum.140236","article-title":"Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects","volume":"41","author":"Diab","year":"2014","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.amjms.2022.01.023_bib0011","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00296-017-3916-x","article-title":"Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group","volume":"38","author":"S\u00e1nchez-Cano","year":"2018","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.023_bib0012","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/rheumatology\/ket163","article-title":"Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort","volume":"52","author":"Marangoni","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.amjms.2022.01.023_bib0013","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.amjms.2022.01.023_bib0014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","article-title":"Diagnosis and classification of systemic sclerosis","volume":"40","author":"Hachulla","year":"2011","journal-title":"Clinic Rev Allerg Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2022.01.023_bib0015","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European respiratory society\/American thoracic society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.amjms.2022.01.023_bib0016","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"American college of rheumatology Ad hoc committee on immunologic testing guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.amjms.2022.01.023_bib0017","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.amjms.2022.01.023_bib0018","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.amjms.2022.01.023_bib0019","first-page":"439","article-title":"Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis","volume":"130","author":"Chapman","year":"1984","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.amjms.2022.01.023_bib0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.amjms.2022.01.023_bib0021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.10760","article-title":"A comparison between anti-Th\/To\u2013 and anticentromere antibody\u2013positive systemic sclerosis patients with limited cutaneous involvement","volume":"48","author":"Mitri","year":"2003","journal-title":"Arthritis Rheumatism"},{"issue":"12","key":"10.1016\/j.amjms.2022.01.023_bib0022","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/art.1780331210","article-title":"Autoantibody to th ribonucleoprotein (nucleolar 7\u20132 rna protein particle) in patients with systemic sclerosis","volume":"33","author":"Okano","year":"1990","journal-title":"Arthritis Rheumatism"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.023_bib0023","first-page":"1600","article-title":"Anti-th\/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis","volume":"33","author":"Fischer","year":"2006","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.amjms.2022.01.023_bib0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2214\/ajr.167.1.8659350","article-title":"The relationship of thoracic lymphadenopathy to pulmonary interstitial disease in diffuse and limited systemic sclerosis: CT findings","volume":"167","author":"Wechsler","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.023_bib0025","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.38702","article-title":"Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?: SSc-associated ILD and IPF","volume":"66","author":"Herzog","year":"2014","journal-title":"Arthritis Rheumatology"},{"issue":"9","key":"10.1016\/j.amjms.2022.01.023_bib0026","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"25","key":"10.1016\/j.amjms.2022.01.023_bib0027","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjms.2022.01.023_bib0028","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","article-title":"Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease","volume":"176","author":"Tashkin","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.amjms.2022.01.023_bib0029","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respiratory Med"},{"issue":"26","key":"10.1016\/j.amjms.2022.01.023_bib0030","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis\u2013associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922000982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922000982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:43:02Z","timestamp":1757702582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922000982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0002962922000982"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.01.023","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}